Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 22, 2017 |
| Target | BioCare Copenhagen A/S |
| Sector | Life Science |
| Buyer(s) | DSM-Firmenich |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1902 |
| Sector | Chemicals |
| Employees | 26,301 |
| Revenue | 12.8B EUR (2024) |
DSM-Firmenich specializes in the development, manufacture, and marketing of performance materials, nutritional and pharmaceutical ingredients, and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing, and electrics & electronics. DSM-Firmenich was founded in 1902 and is based in Kaiseraugst, Switzerland.
| Deal Context for Buyer | # |
|---|---|
| Overall | 26 of 28 |
| Sector: Life Science | 8 of 9 |
| Type: Add-on Acquisition | 18 of 19 |
| Country: Denmark | 1 of 1 |
| Year: 2017 | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-11-17 |
Amyris Brasil
Brazil Amyris Brasil Ltda is an industrial bioscience company, which owns and operates the Brotas 1 production facility. |
Buy | $96M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-06-29 |
Centrient Pharmaceuticals
Rotterdam, Netherlands Centrient Pharmaceuticals is a provider of sustainable antibiotics, next-generation statins and anti-fungals. Centrient develops, produces and sells intermediates, active pharmaceutical ingredients and finished dosage form pharmaceuticals. Centrient Pharmaceuticals is based in Rotterdam, Netherlands. |
Sell | - |
